Dimenhydrinate
| Combination of | |
|---|---|
| Diphenhydramine | Antihistamine, sedative | 
| 8-chlorotheophylline | Stimulant | 
| Clinical data | |
| Trade names | Dramamine, Draminate, Gravol, others | 
| Other names | Diphenhydramine/8-chlorotheophylline salt | 
| AHFS/Drugs.com | Monograph | 
| MedlinePlus | a607046 | 
| License data | |
| Pregnancy category | 
 | 
| Routes of administration | By mouth, rectal, intravascular, intramuscular | 
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Metabolism | Liver | 
| Elimination half-life | 5.5 hours (diphenhydramine component) | 
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.007.593 | 
| (what is this?) (verify) | |
Dimenhydrinate, also known as diphenhydramine/8-chlorotheophylline salt and sold under the brand names Dramamine and Gravol, among others, is an over-the-counter medication used to treat motion sickness and nausea. Dimenhydrinate is a theoclate salt composed of diphenhydramine and 8-chlorotheophylline (a theophylline relative) in a 1:1 ratio.
Dimenhydrinate was introduced to the market by G.D. Searle in 1949.